The comparison with tirzepatide is worth examining carefully, as the dual-agonist approach of tirzepatide may offer additional benefits for some women
FHI-HADH, caused by mutations in HADH, tends to be relatively mild, although severe cases have been reported
Not a single randomized controlled trial exists for the carnivore diet in any autoimmune condition
Cardiovascular Outcomes This section reviews current evidence regarding GLP-1 RAs effects on MACE, PAD, CAD, HF, blood pressure, and AF, with detailed findings of trials and meta-analyses discussed in Tables 1 and 2 Major Adverse Cardiac Events Among Patients with T2DM Strong evidence supports using GLP-1 RAs to reduce MACE among patients with T2DM and established CVD
Medullary thyroid cancer Gallbladder issues Anaphylaxis (severe allergic reaction) Seek immediate medical attention if you experience any severe symptoms on a GLP-1 or other medication